Research articlePublished 28 Nov 2024
The Patentability of Human Genes in Asia: Chinese Law, Comparative Analysis and Future development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The patentability of human genes has long been a controversial topic around the world. The United States Supreme Court denied the patentability of isolated genes but acknowledged that of cDNA in the Myriad case. On the contrary, similar to the attitude of Europe, China grants patent protection to isolated genes upon satisfying certain requirements. However, the related provisions in the Chinese patent legalsystem are far from specific enough. This article introduces the major approaches in the most representative jurisdictions towards this question and their problems respectively. Then this article aims to provide suggestions for the future direction of China on this issue from the perspective of comparative analysis.
Subjects
Social Sciences & HumanitiesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Legal, Ethical and Regulatory Issues
- SubjectSocial Sciences & Humanities
- BylineArticles whose byline prints “Chenguo Zhang”
- BylineArticles whose byline prints “Yichen Zhang”
